Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke


Phase 1/2 Results

Eligibility Criteria

Inclusion Criteria

- Acute ischemic stroke within 12 hours for the first time before entry into the study
- National Institutes of Health Stroke Scale (NIHSS) score between 6 and 25

Exclusion Criteria

- with lacunar infarction
- with cerebral hemorrhagic infarction
- with epilepsy or epileptic persons
- with history of neurological diseases
- with myocardial infarction,
- with renal and hepatic abnormalities
- with metabolic diseases
- with contraindications to antiplatelet treatments